NDRA vs SRPT · P/E 0.0, $2.6M cap vs rev $1.90B
ENDRA Life Sciences Inc (NDRA) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
NDRA does not have a complete income-statement cache yet.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
NDRA currently screens at market cap $2.6M and trailing P/E 0.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the NDRA and SRPT stock pages for the full models.
Not investment advice.